G

Genmab

Transforming Antibody Therapeutics

Copenhagen, Denmark
1,800+

Machine learning & AI jobs at Genmab

Genmab has 5 open machine learning, AI and data science roles on CompBioJobs.

About Genmab

Industry: Biotechnology
Founded: 1999
Founders: Florian Schönharting
Status: Public (NASDAQ: GMAB)

Funding & Growth

Total Raised: N/A
Valuation: $15B+ market cap
Stage: Public
Key Investors:
Public markets

✓ Pros

  • • Leader in antibody therapeutics (Darzalex, bispecifics)
  • • Strong science-driven culture
  • • Global opportunities (Denmark, US, Japan)
  • • Growing computational biology focus
  • • Collaborative team environment

✗ Cons

  • • Smaller than big pharma (fewer roles)
  • • Denmark HQ means some decisions made overseas
  • • Less brand recognition in US vs European markets

🏢 Working Here

Genmab operates with an 'extra[not]ordinary' culture emphasizing authenticity and innovation.

The company has pioneered next-generation antibody technologies including bispecific T-cell engagers, antibody-drug conjugates, and effector function enhanced antibodies.

Scientists work in multidisciplinary, international teams with state-of-the-art knowledge of the antibody and oncology field.

The US headquarters in Princeton, NJ focuses on clinical development and commercial operations, while Copenhagen remains the R&D hub.

Genmab supports employee resource groups including GenPride, GenWEN, and NextGen for early career professionals.

🧬 Bioinformatics Focus

Genmab is transforming antibody discovery using computational biology and bioinformatics. Key areas include:

  • Discovery Data Science - Integrating ML/AI into early drug discovery for antibody optimization.
  • Translational Sciences - Using quantitative approaches to bridge preclinical and clinical development.
  • Computational Immunology - Analyzing immune responses and tumor microenvironment.
  • Single - cell and spatial transcriptomics for understanding antibody mechanisms. The team combines wet lab and computational approaches to optimize bispecific antibodies and ADCs.

📈 Career Growth & Development

📚

Development

Genmab follows a 70-20-10 learning model for professional development.

🎯

Career Tracks

Scientists can progress through individual contributor tracks (Scientist I → Senior → Principal → Distinguished) or move into leadership roles.

🏆

Growth

The company's growth in bispecific antibodies and ADCs creates opportunities in computational biology and translational sciences.

🔄

Mobility

Global mobility between Copenhagen, Princeton, Utrecht, and Tokyo offices is possible.

Perks & Benefits

✓ Competitive healthcare plans
✓ GenCare wellness app and fitness programs
✓ Generous PTO and company gatherings
✓ Retirement plans with matching
✓ Performance bonuses and equity incentives
✓ Learning and development programs

Popular Teams

Discovery Data Science Translational Sciences Computational Biology Antibody Engineering Clinical Bioinformatics

Get weekly job alerts